Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1879-1885

  Schaller, Gerhard ^a   Fuchs, Ilka ^a   Pritze, Wolfgang ^a   Ebert, Andreas ^a   Herbst, Herrmann ^a   Pantel, Klaus ^b   Weitzel, Hans ^a   Lengyel, Ernst ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 18; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029805461     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Carter, C. L., Allen C , and Henson, D. E Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer (Phila.), 63: 181-187, 1989.
2. Harris, J. R., Lippman, M. E., and Veronesi, U. Breast Cancer 1, N. Engl. J. Med., 327: 319-328, 1992.
3. Fisher, B., Redmond, C., Fisher, E. R., and Caplan, R. Relative worth of estrogen and progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J. Clin. Oncol., 6: 1076-1087, 1988.
4. r 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res., 49: 6008-6014, 1989.
5. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-235, 1987.
6. Altmannsberger, M., Dirk, T., Droese, M., Weber, K., and Osbom, M. Keratin polypeptide distribution in benign and malignant breast tumours: subdivision of ductal carcinomas using monoclonal antibodies. Virchows Arch B Cell Pathol. Incl. Mol. Pathol., 51: 265-275, 1986.
7. Moll, R. Cytokeratins as Markers of Differentiation: Expression Profiles in Epithelia and Epithelial Tumors, pp. 90-96. New York: Gustav Fischer Stuttgart. Jena, 1993.
8. Bhattacharya, B., Prasad, G. L., Valerius, E. M., Salomon, D. S., and Cooper, H. L. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res., 50: 2105-2112, 1990.
9. Moll, R., Franke, W., and Schiller, D. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell, 31: 11-24, 1982.
10. Chu, Y. W , Runyan, R. B., Oshima, R. G., and Hendrix, M. J. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA, 90: 4261-4265, 1993.
11. Schaller, G., Lengyel, E, Pantel, K., Hardt, W., and Mischke, D. Keratin expression reveals mosaic differentiation in vaginal epithelium. Am J Obstet Gynecol., 169: 1603-1607, 1993.
12. Moll, R., Zimbelmann, R., Goldschmidt, M. D., Keith, M., Laufer, J., Kasper, M., Koch, P. J., and Franke, W. W. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation, 53: 75-93, 1993.
13. Taylor-Papadimitriou, J., and Lane, E. B. Keratin expression in the mammary gland. In: M. C. Neville and C. Daniels (eds.), The Mammary Gland: Development, Regulation and Function, pp. 181-215. New York: Plenum Publishing Corp., 1987.
14. Jarasch, E. D , Nagle, R. B., Kaufmann, M., Maurer, C., and Bocker, W. J. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum. Pathol., 3: 276-288, 1988.
15. Pellegrino, M. B., Asch, B. B., Connolly, J. L., and Asch, H. L. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8. 12, Cancer Res., 48: 5831-5836, 1988.
16. Zhang, R. D., Fidler, I., and Price, J. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis, 11: 204-215, 1991.
17. Cordell, J. L., Fallini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A , Stein, H., and Mason, D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32: 219-229, 1984.
18. Remmele, W., and Stegner, H E. Immunhistochemischer Nachweis von Östrogenrezeptoren (Er-ICA) im Mammakarzinomgewebe. Vorschlag zur einheitlichen Bewertung des Untersuchungsbefundes. Der Frauenarzt, 2: 41-43, 1987.
19. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
20. Trask, D. K., Band, V., Zajchowski, D. A., Yaswen, P., Suh, T., and Sager, R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc. Natl. Acad. Sci. USA, 87: 2319-2323, 1990.
21. Pankov, R., Umezawa, A , Maki, R., Der, C. J., Hauser, C. A., and Oshima, R. G. Oncogene activation of human keratin 18 transcription via the Ras signal transduction. Proc. Natl. Acad. Sci. USA, 91: 873-877, 1994.
22. Diaz-Guerra, M., Haddow, S., Bauluz, C., Jorcano, J. L., Cano, A., Balmain, A., and Quintanilla, M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations. Cancer Res., 52: 680-687, 1992.
23. Caulin, C., Bauluz, C., Gandarillas, A., Cano, A., and Quintanilla, M. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes. Exp. Cell Res., 204: 11-21, 1993
24. Lichtner, R. B., Julian, J. A., North, S. M., Glaser, S. R., and Nicolson, G. L. Coexpression of cytokeratins characteristic for myoepithelial and luminal cell lineages in rat 13762NF mammary adenocarcinoma tumors and their spontaneous metastases. Cancer Res., 51: 5943-5950, 1991.
25. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell Physiol., 150: 534-544, 1992.